Phathom Pharmaceuticals Inc. (PHAT)
NASDAQ · Healthcare
Phathom Pharmaceuticals Inc. annual/quarterly long term debt history from 2022 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Phathom Pharmaceuticals Inc. long term debt for the quarter ending December 31, 2025 were 209.1M, a 3.81% increase year-over-year.
- Phathom Pharmaceuticals Inc. long term debt for 2025 were 209.1M, a 3.81% increase from 2024.
- Phathom Pharmaceuticals Inc. long term debt for 2024 were 201.4M, a 46.12% increase from 2023.
- Phathom Pharmaceuticals Inc. long term debt for 2023 were 137.8M, a 44.69% increase from 2022.
- Phathom Pharmaceuticals Inc. long term debt for 2022 were 95.3M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Phathom Pharmaceuticals Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $209 |
| 2024 | $201 |
| 2023 | $138 |
| 2022 | $95 |
| Phathom Pharmaceuticals Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2025-12-31 | $209 |
| 2024-12-31 | $201 |
| 2023-12-31 | $138 |
| 2022-12-31 | $95 |
Phathom Pharmaceuticals Inc. Long Term Debt — FAQ
Phathom Pharmaceuticals Inc. (PHAT) long term debt over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PHAT's long term debt history?
The chart and table above show Phathom Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.